Navigation Links
John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva

GENEVA, July 11, 2014 /PRNewswire/ --

EPFL and the University of Geneva (UNIGE) are pleased to announce the appointment of John P. Donoghue. The American neuroscientist is to head the Wyss Center at Campus Biotech  in Geneva.

The new Wyss Center for Bio- and Neuro-Engineering, located on Campus Biotech in Geneva, has named as its director one of the most internationally recognised neuroscientists. John P. Donoghue, founder of Brown University's Institute for Brain Science, has been appointed adjunct professor at EPFL and visiting professor at the University of Geneva. He is best known for having developed innovative brain-computer interfaces for people with paralysis.

Professor of neuroscience and engineering at Brown University (Rhode Island, USA) and holder of the Henry Merritt Wriston chair, John P. Donoghue is one of the founding fathers of the merger between neuroscience and cybernetics, now called neuroprosthetics.

The new Wyss Center for Bio-and Neuro-Engineering is currently being implemented on the Campus Biotech site in Geneva, on the former site of Merck Serono. Campus Biotech will host more than a dozen new laboratories devoted to research in areas such as neuroengineering and regenerative engineering. The Wyss Center will provide research platforms and innovative funding to translate technology to new medical devices. The Center is funded by the Wyss Foundation, founded by Swiss entrepreneur Hansjoerg Wyss. The Wyss Center is expected to attract scientists and engineers worldwide to Campus Biotech.

"The Wyss Center will promote collaboration among the world's leading scientific minds and also provide access to the financial and business expertise that can translate cutting-edge research into viable treatments. John Donoghue's leadership in neuroscience and entrepreneurial spirit have proven that he is a global thought leader and the ideal candidate to lead the Center", declares Hansjoerg Wyss, President of the Wyss Foundation.

John P. Donoghue is the founding Chairman of the Department of Neuroscience at Brown, and directs the Brown Institute for Brain Science in Rhode Island, USA ( He will take a one year sabbatical from Brown in 2015 during which he will be devoted to his position as Head of the Wyss Center.

"The biotechnology and life sciences industry is entering a tremendous phase of growth with new discoveries beginning to make their impact globally for human health and well being.

The vision of the Campus and the principles on which the Center is founded create a unique opportunity to help contribute to, and reshape, how we think about biotechnology and life sciences in the context of modern science, business and sustainable development. I am excited to be part of this new initiative, to maximize collaboration, and to join other teams at Campus Biotech to revolutionize the sector." said John P. Donoghue.

John P. Donoghue is one of the most recognised researchers in the neuroengineering field. He has won numerous awards, such as the 2007 KJ Zülch Prize, the highest European distinction for neurological research. He skilfully combines the qualities of a scientist, engineer and manager, for example by coordinating the multidisciplinary team behind the ground-breaking prototype neural interface known as BrainGate.

Campus Biotech 

Campus Biotech is a world-leading site for advanced biotechnology and neurosciences in

Switzerland that unites expertise, investment and entrepreneurialism to translate cutting edge research into products and solutions that will transform the world. With access to the very best scientific talent from across the globe, the multidisciplinary campus unites business, academic institutions and organisations who share a common vision of making the future of science accessible today. Campus Biotech is committed to tackling the most pressing challenges in biotechnology and life sciences to change the world.

SOURCE Campus Biotech
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Taking solar technology up a notch
2. Wysebridge Encourages Taking The Patent Bar Before Major Exam Changes Are Implemented
3. Trending HealthEconomics.Com Pharma Pricing, Reimbursement, and Health Policy Stories Show Healthcare Payers Aren’t Taking Drug Prices Laying Down
4. Shark Branding Corp. CEO Daymond John and Fuse Science CEO Brian Tuffin to be interviewed on Bloomberg Televisions "Taking Stock with Pimm Fox"
5. Waterloo Heights, a Neighborhood Smiles Dental Practice is Taking a Bold New Approach to the Cavity Epidemic
6. Taking a new look at carbon nanotubes
7. Spherix CEO, Anthony Hayes Appears on Bloombergs "Taking Stock With Pimm Fox"
8. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
9. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
10. Eye Surgery Center of Michigan First in Southeast Michigan to Perform Bladeless Cataract Surgery Using New LenSx® Laser Technology
11. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
Post Your Comments:
(Date:11/24/2015)... 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) ... president and chief executive officer, will present at the 27 ... New York City . The presentation will ... 2015 at 9:30 a.m. EST. and ... at least 15 minutes prior to the presentation to allow ...
(Date:11/24/2015)... According to two new studies, fewer men are having PSA ... doctors, scientists, and public health experts have been pushing for ... being done, will there be more men dying of ... "Despite the efforts made in regards to early detection for ... of death in men, killing approximately 27,500 men this year. ...
(Date:11/23/2015)... 2015 China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... preliminary unaudited financial results for the second quarter and ... 2015. --> --> ... for the second quarter of fiscal 2016 increased by ...
(Date:11/23/2015)... , November 23, 2015 ... to develop daclatasvir for 112 ... countries   --> --> ... for a hepatitis C medicine, signing an agreement with Bristol-Myers ... to help cure multiple genotypes of the HCV virus.  The ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):